iTeos Therapeutics (ITOS) Earnings Date, Estimates & Call Transcripts → 🚀 Tap into this explosive trade opportunity asap (From Daily Strike Alliance) (Ad) Free ITOS Stock Alerts $16.99 -0.16 (-0.93%) (As of 12:27 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 10) -$1.07 Missed By -$0.05 Consensus EPS (May. 10) -$1.02 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueITOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ITOS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. iTeos Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($1.22)($0.89)($1.06)Q2 20242($1.15)($0.99)($1.07)Q3 20242($1.21)($1.11)($1.16)Q4 20242($1.25)($1.24)($1.25)FY 20248($4.83)($4.23)($4.53)Q1 20251($1.40)($1.40)($1.40)Q2 20251($1.52)($1.52)($1.52)Q3 20251($1.64)($1.64)($1.64)Q4 20251($1.78)($1.78)($1.78)FY 20254($6.34)($6.34)($6.34)ITOS Earnings Date and InformationiTeos Therapeutics last released its quarterly earnings results on May 10th, 2024. The reported ($1.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.02) by $0.05. iTeos Therapeutics has generated ($3.78) earnings per share over the last year (($3.78) diluted earnings per share). Earnings for iTeos Therapeutics are expected to decrease in the coming year, from ($4.57) to ($5.76) per share. iTeos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More iTeos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/10/2024Q1 2024($1.02)($1.07)($0.05)($1.07)--3/6/2024Q4 2023($1.03)($0.85)+$0.18($0.85)$37.41 million-11/7/2023Q3 2023($1.20)($0.90)+$0.30($0.90)--8/8/2023Q2 2023($1.03)($0.96)+$0.07($0.96)--5/10/2023Q1 2023($0.99)($0.44)+$0.55($0.44)$13.80 million$12.60 million3/15/2023Q4 2022$0.42$0.57+$0.15$0.57$41.16 million$53.91 million1k a day while computer does all work? (Ad)Does your computer make you 1k a day? If not… you don’t need a new computer… You need to learn how to set it up so it makes you money. Click here to register.11/10/2022Q3 2022$0.07$0.03($0.04)$0.03$42.05 million$19.49 million8/10/2022Q2 2022$1.20$0.15($1.05)$0.15$96.95 million$41.72 million5/12/2022Q1 2022$0.80$1.82+$1.02$1.82$63.30 million$152.52 million 3/23/2022Q4 2021$1.29$4.88+$3.59$4.88$85.45 million$240.50 million11/10/2021Q3 2021$4.95$1.86($3.09)$1.86$329.75 million$104.27 million 8/12/2021Q2 2021($0.41)($0.75)($0.34)($0.75)-- 5/13/2021Q1 2021($0.48)($0.39)+$0.09($0.39)-- 3/24/2021Q4 2020-($0.43)($0.43)($0.43)--11/12/2020Q3 2020($0.37)($0.48)($0.11)($0.48)-- iTeos Therapeutics Earnings - Frequently Asked Questions When is iTeos Therapeutics's earnings date? iTeos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ITOS's earnings history. Did iTeos Therapeutics beat their earnings estimates last quarter? In the previous quarter, iTeos Therapeutics (NASDAQ:ITOS) missed the analysts' consensus estimate of ($1.02) by $0.05 with a reported earnings per share (EPS) of ($1.07). Learn more on analysts' earnings estimate vs. ITOS's actual earnings. How much revenue does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded annual revenue of $12.60 million. How much profit does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of -$112.64 million. ITOS has generated -$3.78 earnings per share over the last four quarters. What is iTeos Therapeutics's EPS forecast for next year? iTeos Therapeutics's earnings are expected to decrease from ($4.57) per share to ($5.76) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Kyverna Therapeutics Earnings Cabaletta Bio Earnings HilleVax Earnings Valneva Earnings Exscientia Earnings REGENXBIO Earnings Taysha Gene Therapies Earnings Alector Earnings Adaptive Biotechnologies Earnings CARGO Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:ITOS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThis unknown company solves the biggest issue with AIManward PressWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesDems have chosen Biden replacement?Paradigm PressGet out of dollars—get into America’s new money insteadStansberry ResearchDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.